Clinical trial

A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer

NCT02297425

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE2

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2015-01-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLCunresolved

Interventions

PF-06459988DRUG

Sponsors & collaborators

Pfizerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02297425 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.